PYO BACTERIOPHAGE SUPPOSITORIA

Description
PYO Bacteriophage is a mixture of sterile filtrates of phagolysates of the Streptococcal, Staphylococcal, E.coli, Pseudomonas aureginosa and Proteus.

Pharmacological Effect
Causes specific lysis of Staphylococcus aureus, Streptococcus spp, different serotypes of Escherichia coli, Pseudomonas aeruginosa, Proteus Vulgaris and mirabilis.

Prescription
Treatment and prophylaxis of purulent-inflammatory and enteric infectious diseases caused by the microorganisms mentioned above.

Indications

• Otorhinolaryngologic and respiratory bacterial infectious diseases (rhinitis, otitis, inflammation of the paranasal sinuses, pyogenic tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleuritis);
• Dermatologic infections diseases: pyoderma, furunculi, carbuncles, hidradenitis, deep infiltrates and abscesses,
• Surgical infections: phlegmon, bursitis, tendovaginitis, osteomyelitis, paraproctitis, purulent complicated wounds, burns with secondary infections, mastitis.
• Uro-genital infections: urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingo-oophoritis.
• Gastrointestinal infectious diseases: gastroenterocolitis. dysbacteriosis (bacterial overgrowth syndrome);
• Inflammatory processes in the oral cavity: stomatitis, gingivitis and paradonititis,
• Eye infections: conjunctivitis and blepharitis.
• Generalized septic diseases.
• Various purulent-inflammatory infections, including omphalitis, pyoderma, sepsis in children (including neonates)
• Diseases induced by post-surgical complications.

Contraindications
There are no contraindications ever observed for pyobacteriophage.

Packaging and Storage Conditions
The preparation comes in 35g, (10 pieces)

Shelf life: 3 months.

Conditions of release: Out of prescription)

Developed by: G.Eliava Institute of bacteriophage, Microbiology and virology.